Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: The APOLLOtrial

Koon K. Teo, Marc Pfeffer, Giuseppe Mancia, Martin O'Donnell, Gilles Dagenais, Rafael Diaz, Antonio Dans, Lisheng Liu, Jackie Bosch, Philip Joseph, Ingrid Copland, Hyejung Jung, Janice Pogue, Salim Yusuf

Research output: Contribution to journalArticle

Abstract

Aims: We studied the unclear question whether blood pressure (BP) lowering reduces cardiovascular disease (CVD) in elderly individuals with systolic BP

Original languageEnglish
Pages (from-to)1743-1751
Number of pages9
JournalEuropean Heart Journal
Volume35
Issue number26
DOIs
Publication statusPublished - Jul 7 2014

    Fingerprint

Keywords

  • Aliskiren
  • Clinical trial
  • Combination therapy
  • Direct renin inhibitor
  • Lowering stage 1 hypertension in elderly

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Teo, K. K., Pfeffer, M., Mancia, G., O'Donnell, M., Dagenais, G., Diaz, R., Dans, A., Liu, L., Bosch, J., Joseph, P., Copland, I., Jung, H., Pogue, J., & Yusuf, S. (2014). Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: The APOLLOtrial. European Heart Journal, 35(26), 1743-1751. https://doi.org/10.1093/eurheartj/ehu079